Extranodal NK/T-cell lymphoma, nasal type: A report of 73 cases at MD anderson cancer center

American Journal of Surgical Pathology

Volumn 37, Issue 1, 2013, Pages 14-23

  Li, Shaoying ^a   Feng, Xiaoli ^a   Li, Ting ^b   Zhang, Shuang ^b   Zuo, Zhuang ^a   Lin, Pei ^a   Konoplev, Sergej ^a   Bueso Ramos, Carlos E ^a   Vega, Francisco ^a   Medeiros, L Jeffrey ^a   Yin, C Cameron ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

extranodal NK T cell lymphoma; nasal type; southern United States

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CELL PROLIFERATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; NOSE TUMOR; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PROGNOSIS; SURVIVAL RATE; UNITED STATES; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; COMBINED MODALITY THERAPY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NEOPLASM STAGING; NOSE NEOPLASMS; PROGNOSIS; RNA, VIRAL; SURVIVAL RATE; TEXAS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84871614389     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31826731b5     Document Type: Article

References (28)

1. Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NK, et al, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008:285-288.
2. Gualco G, Domeny-Duarte P, Chioato L, et al. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol. 2011;35:1195-1203.
3. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113:3931-3937.
4. Cabrera ME, Martinez V, Nathwani BN, et al. Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists. Leuk Lymphoma. 2012;53:1311-1317.
5. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24:612-618.
6. Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood. 2008;112:3057-3064.
7. Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol). 2008;20:619-625.
8. Barrionuevo C, Zaharia M, Martinez MT, et al. Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol. 2007;15:38-44.
9. Panano L, Gallamini A, Trape G, et al. NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol. 2006;17:794-800.
10. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688-2695.
11. Medeiros LJ, Jaffe ES, Chen YY, et al. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol. 1992;16:439-447.
12. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer. 1996;77:2137-2149.
13. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335:128-130.
14. Kanungo A, Medeiros LJ, Abruzzo LV, et al. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol. 2006;19:25-33.
15. Zhang S, Li T, Zhang B, et al. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas. Hum Pathol. 2011;42:1319-1348.
16. Yin CC, Lin P, Carney DA, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005;123:594-602.
17. Vega F, Medeiros LJ, Jones D, et al. A novel four-color PCR assay to assess T-cell receptor gamma gene rerarrangements in lympho-proliferative lesions. Am J Clin Pathol. 2001;116:17-24.
18. Thompson MA, Habra MA, Routbort MJ, et al. Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adults. Am J Hematol. 2007;82:299-303.
19. Oshimi K, Kawa K, Nakamura S, et al. NK-cell neoplasms in Japan. Hematology. 2005;10:237-245.
20. Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and ab, rd, and ab/gd T-cell origin: a comprehensive clinicopatho-logic and phenotypic study. Am J Surg Pathol. 2012;36:481-499.
21. Kim SJ, Kim BS, Choi CW, et al. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lympho-ma, nasal type. Ann Oncol. 2007;18:1382-1387.
22. Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer. 2005;41:1402-1408.
23. Harabuchi Y, Takahara M, Kishibe K, et al. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol. 2009;14:181-190.
24. Lim ST, Hee SW, Quek R, et al. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Eur J Haematol. 2008;80:55-60.
25. Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17:1097-1107.
26. Bossard C, Belhadj K, Reyes F, et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 2007;109:2183-2189.
27. Huang JJ, Zhu YJ, Xia Y, et al. A novel prognostic model for extranodal natural killer/T-cell lymphoma. Med Oncol. 2011. [Epub ahead of print].
28. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definition, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.